Marc Belsky
2017 - Five Prime Therapeutics
In 2017, Marc Belsky earned a total compensation of $1.9M as Senior Vice President and Chief Financial Officer at Five Prime Therapeutics, a 16% increase compared to previous year.
Compensation breakdown
| Bonus | $87,500 |
|---|---|
| Non-Equity Incentive Plan | $144,210 |
| Option Awards | $633,920 |
| Salary | $380,125 |
| Stock Awards | $672,190 |
| Other | $9,457 |
| Total | $1,927,402 |
Belsky received $672.2K in stock awards, accounting for 35% of the total pay in 2017.
Belsky also received $87.5K in bonus, $144.2K in non-equity incentive plan, $633.9K in option awards, $380.1K in salary and $9.5K in other compensation.
Rankings
In 2017, Marc Belsky's compensation ranked 5,685th out of 14,666 executives tracked by ExecPay. In other words, Belsky earned more than 61.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,685 out of 14,666 | 61st |
Division Manufacturing | 2,061 out of 5,768 | 64th |
Major group Chemicals And Allied Products | 636 out of 2,074 | 69th |
Industry group Drugs | 490 out of 1,730 | 72nd |
Industry Pharmaceutical Preparations | 385 out of 1,329 | 71st |
Source: SEC filing on March 30, 2018.
Belsky's colleagues
We found four more compensation records of executives who worked with Marc Belsky at Five Prime Therapeutics in 2017.